CureVac Aktie
Diese Aktie wird nicht mehr gehandelt
Diese Analysten bewerten die CureVac-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Jefferies & Company Inc. | 5,00 USD | - | 13.06.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 7 | 1 | 1 | 141,80 GBP | - |
| Bayer | 5 | 4 | 1 | 39,67 EUR | +2,63% |
| BioNTech (ADRs) | 4 | 1 | 0 | 136,40 USD | +59,20% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 2 | 4 | 3 | 43,68 EUR | +13,01% |
| Fresenius SE & Co. KGaA (St.) | 7 | 2 | 0 | 54,32 EUR | +22,84% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 116,88 CHF | -2,32% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 5 | 0 | 28,33 USD | +4,77% |
| Roche Holding AG Inhaber-Partizipationsschein | 4 | 4 | 1 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 97,62 EUR | +21,51% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |